RECENT POSTS

20

Jul, 2014

New Corporate Alliances & Conferences

By: | Tags: | Comments: 0

BioMark is actively pursuing international business and research collaborations to increase its global footprint. North America N. America is a critical market for technology development and commercial acceleration. BioMark is in discussions with 4 potential companies located in Boston, Maryland, San Diego and San Francisco. Both the East and West coast corridors are important centres for biotechnology and medical device markets International BioMark’s international partners are located in China, Bangladesh…

READ MORE

18

Jul, 2014

BioMark News Summary 2007 – 2012

By: | Tags: | Comments: 0

Clinical Trial and Gene Expression Ethics Approval BioMark has received conditional approval from the University of Manitoba and CancerCare Manitoba for 2 studies that will commence shortly. The studies involve phase III clinical trial and SSAT Gene Expression in…

READ MORE

18

Jul, 2014

BioMark is proud to announce

By: | Tags: | Comments: 0

NRC – IRAP Funding for 2013 – BioMark will be funded generously by NRC with emphasis on developing prototypes for cancer screening kits using antibodies generated at UBC and IR Raman based technologies currently being developed at UVic.Both systems are targeted for use when the trials are completed at CancerCare Manitoba in 2013. Engage Grant approval with Dr. Farser Hof of UVic for further chemical method development related to specific…

READ MORE